ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Siliq (brodalumab) approved by the US FDA for adult patients with moderate-to-severe plaque psoriasi
February 20, 2017AstraZeneca's partner Valeant Pharmaceuticals today announced that the US Food and Drug Administration (FDA) has approved Siliq (brodalumab) injection for the treatment of adult patients... -
AstraZeneca Siliq (brodalumab) approved by the US FDA for adult patients with moderate-to-severe pla
February 17, 2017AstraZeneca's partner Valeant Pharmaceuticals today announced that the US Food and Drug Administration (FDA) has approved Siliq (brodalumab) injection for the treatment of adult patients with moderate-to-severe plaque psoriasis who are candidates for syst -
AstraZeneca awards grants for new programmes to improve heart health
February 10, 2017AstraZeneca is awarding grants from its Connections for Cardiovascular Health programme to non-profit organisations that address the challenges of preventing and controlling cardiovascular disease by conducting programmes for at-risk groups. -
AstraZeneca Releases Full-Year and Q4 2016 Results
February 06, 2017Pascal Soriot, Chief Executive Officer, commenting on the results said:
Pharma Sources Insight January 2025
